[Registries for neurological drugs landscape].


In Italy we can mention two experiences related to the use of registries for neurological drugs. The first one involved the use of cholinesterase inhibitors (donepezil, rivastigmine, galantamine) in the treatment of probable Alzheimer's dementia of mild-moderate level; the second, currently in progress, concerned the use of natalizumab for the treatment of… (More)
DOI: 10.1701/1295.14328


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics